[Answered] Sympathomimetic bronchodilators may cause a decrease in heart rate, drowsiness, and fatigue. ...

This topic contains a solution. Click here to go to the answer

Author Question: Sympathomimetic bronchodilators may cause a decrease in heart rate, drowsiness, and fatigue. ... (Read 15 times)

DyllonKazuo

Hero Member
Posts: 565

on: Jun 25, 2018

Sympathomimetic bronchodilators may cause a decrease in heart rate, drowsiness, and fatigue.

Indicate whether the statement is true or false

Question 2

Tablets that are made with granular salts that release active ingredients when placed in water are called:
A) effervescent
B) chewable
C) sublingual
D) enteric-coated

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

nital

Sr. Member
Posts: 320

Reply #1 on: Jun 25, 2018

Answer to Question 1

False

Answer to Question 2

A

DyllonKazuo

Member
Posts: 565

Reply 2 on: Jun 25, 2018

Gracias!

ktidd

Member
Posts: 319

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.